As More Americans Embrace Anxiety Treatment, RFK Jr. Derides Medications

February 23, 2026

TL;DR

The percentage of American adults taking anxiety medication rose from 11.7% in 2019 to 14.3% in 2024, with a notable increase during the COVID-19 pandemic.
Robert F. Kennedy Jr. has criticized SSRIs, suggesting they are difficult to quit and may be linked to violent behavior.
Medical professionals and researchers defend SSRIs, stating they are front-line treatments proven safe for extended use and that claims of addiction are largely unsubstantiated.
A comprehensive study indicated that over half of individuals with generalized anxiety disorder taking an SSRI experienced a significant reduction in symptoms.
While side effects like upset stomach and reduced libido can occur, they are often mild and manageable for many patients.
Benzodiazepines, a different class of anxiety medication, are noted as habit-forming and more prone to addiction, requiring careful monitoring.
Factors contributing to increased anxiety medication use include social media, isolation, economic uncertainty, and greater accessibility through telehealth.
Young adults (ages 18-34) are a driving force behind the rise in anxiety medication use, with rates increasing from 8.8% in 2019 to 14.6% in 2024.

Continue reading the original article